Literature DB >> 9149357

Bone mineral analysis in patients with biliary atresia after successful Kasai procedure.

A Toki1, T Todani, Y Watanabe, Y Sato, K Ogura, M Yoshikawa, S Yamamoto, Z Q Wang.   

Abstract

Metabolism is probably disturbed in patients with abnormal liver function who have undergone a successful Kasai procedure. We examined bone mineral metabolism in patients who have successfully undergone Kasai procedure. Bone mineral metabolism was examined in 8 patients with biliary atresia after a successful Kasai procedure. Five patients were female and 3 were male. The ages at Kasai procedure ranged from 50 to 80 days, and the follow-up periods ranged from 3 to 27 years after the operation. All patients eat a normal oral diet. We examined plasma levels of 25-OH-D3, 1, 25-(OH)2-D3, Ca and phosphorus (P). Bone mineral content of the lumbar spine (L2-L4) was assessed by dual energy x-ray absorptiometry (DEXA), and the data were expressed as a bone mineral density (BMD). Two patients showed abnormal levels on hepatic function tests. Plasma levels of 1, 25-(OH)2-D3, Ca, and P were normal in all patients. The level of 25-OH-D3 was normal in 7 patients. BMD levels were normal in 6 patients, but low in 2 who had undergone partial splenic embolization and splenectomy, respectively, due to hypersplenism. In long-term survivors of Kasai procedure, measurement of BMD may detect bone mineral deficiency earlier than measurements of serum levels of 25-OH-D, 1, 25-(OH)2-D, Ca and P.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9149357     DOI: 10.1620/tjem.181.213

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  2 in total

1.  Hepatic osteodystrophy complicated with bone fracture in early infants with biliary atresia.

Authors:  Tadao Okada; Shohei Honda; Hisayuki Miyagi; Masashi Minato; Akinobu Taketomi
Journal:  World J Hepatol       Date:  2012-10-27

2.  Bone health in a nonjaundiced population of children with biliary atresia.

Authors:  Rachel A Kramer; Babette S Zemel; Jessica L Arvay-Nezu; Virginia A Stallings; Mary B Leonard; Barbara A Haber
Journal:  Gastroenterol Res Pract       Date:  2009-07-05       Impact factor: 2.260

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.